Corporate News 09-May-24
Board of Alembic Pharmaceuticals recommends final dividend
Of Rs 11 per share
Alembic Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 9 May 2024, inter alia, have recommended the final dividend of Rs 11 per equity Share (i.e. 550%) , subject to the approval of the shareholders.
Previous News
Alembic Pharma gets US FDA nod for heart failure-treatment drug
( Hot Pursuit - 30-May-24 14:05 )
Alembic Pharma gets USFDA nod for Icatibant injection
( Hot Pursuit - 17-Jun-24 14:03 )
Volumes spurt at Alembic Pharmaceuticals Ltd counter
( Hot Pursuit - 24-Apr-23 14:30 )
USFDA inspects Alembic Pharma's solid oral formulation facility at Jarod
( Corporate News - 19-Dec-22 12:51 )
Alembic Pharma gets USFDA nod for Doxycycline Capsules
( Hot Pursuit - 28-Jun-24 12:20 )
Alembic Pharmaceuticals announces board meeting date
( Corporate News - 19-Jan-24 14:13 )
Alembic Pharma gets USFDA nod for Desonide cream
( Hot Pursuit - 09-Dec-22 11:01 )
Alembic Pharmaceuticals to acquire 40% stake in Aleor Dermaceuticals
( Corporate News - 29-Mar-22 15:41 )
Alembic Pharma gets tentative USFDA nod for Brexpiprazole tablets
( Hot Pursuit - 09-Mar-23 09:18 )
Alembic Pharma gets USFDA final approval for Prazosin Hydrochloride capsules
( Hot Pursuit - 08-Mar-23 09:19 )
Alembic Pharmaceuticals receives USFDA tentative approval for Dronedarone Tablets
( Corporate News - 10-Jan-22 10:59 )
Other Stories
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Akme Fintrade (India) to announce Quarterly Result
03-Jul-24 17:43
Ponni Sugars (Erode) to hold board meeting
03-Jul-24 17:43
Aditya Vision to conduct AGM
03-Jul-24 17:43
Back
Top
